Literature DB >> 23929496

Emerging roles of microRNA in modulating cell-death processes in malignant glioma.

Silvia Palumbo1, Clelia Miracco, Luigi Pirtoli, Sergio Comincini.   

Abstract

MicroRNAs (miRNAs) are small noncoding RNA molecules that regulate protein expression by cleaving or repressing the translation of target mRNAs. In mammals, their function mainly represses the mRNA transcripts via imperfect complementary sequences in the 3'UTR of target mRNAs. Several miRNAs have been recently reported to be involved in modulation of different genes in tumors, including glioblastoma, the most frequent brain tumor in adults. Despite the improvements in treatments, survival of patients remains poor, and glioblastoma is one of the most lethal form of human cancer. To define novel strategies against this tumor, emerging research investigated miRNAs involvement in glioblastoma. In particular, this review is focused on miRNAs involved on the two principal programmed cell-death, apoptosis and autophagy, recently described from the literature. Moreover, the discovery of miRNAs role in glioma cell-death pathways has also revealed a new category of therapeutic targets, fundamental for this kind of tumor.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23929496     DOI: 10.1002/jcp.24446

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  24 in total

1.  MicroRNA-218 inhibits gastrointestinal stromal tumor cell and invasion by targeting KIT.

Authors:  Rong Fan; Jie Zhong; Sichang Zheng; Zhengting Wang; Ying Xu; Shuyi Li; Jie Zhou; Fei Yuan
Journal:  Tumour Biol       Date:  2013-12-29

Review 2.  MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases.

Authors:  Sara De Iudicibus; Marianna Lucafò; Stefano Martelossi; Chiara Pierobon; Alessandro Ventura; Giuliana Decorti
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

3.  MEK inhibitor effective against proliferation in breast cancer cell.

Authors:  Yan Zhou; Hai-Yan Hu; Wei Meng; Ling Jiang; Xing Zhang; Jing-Jing Sha; Zhigang Lu; Yang Yao
Journal:  Tumour Biol       Date:  2014-06-18

4.  Neuropilin-1 (NRP-1)/GIPC1 pathway mediates glioma progression.

Authors:  Guilong Zhang; Lukui Chen; Kouhong Sun; Ahsan Ali Khan; Jianghua Yan; Hongyi Liu; Ailin Lu; Ning Gu
Journal:  Tumour Biol       Date:  2016-08-01

5.  MicroRNA-221 induces autophagy through suppressing HDAC6 expression and promoting apoptosis in pancreatic cancer.

Authors:  Yifan Yang; Yang Sun; Huaitao Wang; Hansi Li; Mingjie Zhang; Lei Zhou; Xiangli Meng; Yunhao Wu; Peng Liu; Xin Liu; Jun Zhang; Xiaodong Tan
Journal:  Oncol Lett       Date:  2018-09-27       Impact factor: 2.967

6.  Regulatory role of miR-129 and miR-384-5p on apoptosis induced by oxygen and glucose deprivation in PC12 cell.

Authors:  Hui-Lin Guan; Yue Guan; Wen-Yuan Li; Jia-Wei Liu; Yu-Jia Zheng; Yan-Zhong Guan; Hong-Feng Liu; Li-Xin Guan; Feng-Guo Zhai
Journal:  Exp Brain Res       Date:  2021-10-18       Impact factor: 1.972

7.  Low MiR-149 expression is associated with unfavorable prognosis and enhanced Akt/mTOR signaling in glioma.

Authors:  Liang Xue; Yi Wang; Shuyuan Yue; Jianning Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

8.  microRNA-218 suppresses the proliferation, invasion and promotes apoptosis of pancreatic cancer cells by targeting HMGB1.

Authors:  Zhe Liu; Yuanhong Xu; Jin Long; Kejian Guo; Chunlin Ge; Ruixia Du
Journal:  Chin J Cancer Res       Date:  2015-06       Impact factor: 5.087

9.  miR-141 suppresses proliferation and motility of gastric cancer cells by targeting HDGF.

Authors:  Bitao Chen; Tao Huang; Jun Jiang; Lei Lv; Hongxing Li; Shitao Xia
Journal:  Mol Cell Biochem       Date:  2013-11-26       Impact factor: 3.396

Review 10.  Autophagy inhibition is the next step in the treatment of glioblastoma patients following the Stupp era.

Authors:  Xiaoran Zhang; Christopher P Deibert; Wi-Jin Kim; Emade Jaman; Aparna V Rao; Michael T Lotze; Nduka M Amankulor
Journal:  Cancer Gene Ther       Date:  2020-08-05       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.